Literature DB >> 16239974

The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.

Harun Evrengul1, Turgay Celek, Halil Tanriverdi, Asuman Kaftan, Dursun Dursunoglu, Mustafa Kilic.   

Abstract

BACKGROUND: Preinfarction angina (PA) and early reperfusion of infarct-related arteries have been shown to reduce infarct size in patients with acute myocardial infarction (AMI). The beneficial effects of PA on infarct size have been attributed to the development of ischemic preconditioning and faster coronary recanalization in patients treated with thrombolytic therapy (TT).
OBJECTIVE: To evaluate the effect of PA on clinical coronary reperfusion time in patients with AMI receiving successful TT.
METHODS: Seventy-five patients presenting with AMI (within 6 h after the initial onset of symptoms) were studied. All patients received TT and were evaluated with coronary angiography (CA) at predischarge. The patients were divided into two groups: group 1 (PA-positive) comprised those who experienced a new onset of prodromal angina within 72 h before the onset of AMI. Group 2 (PA-negative) comprised those who had a sudden onset of AMI without the preceding angina. The successful myocardial reperfusion criteria after TT were ST segment resolution of 50% or greater, the appearance of reperfusion arrhythmias and the resolution of chest pain. The time of reperfusion criteria was recorded after TT. CA was performed in all patients at predischarge. Patients with no patent infarct-related arteries on CA and clinical failure of reperfusion were excluded from the study.
RESULTS: Clinical characteristics, risk factors and angiographic findings did not differ significantly between the groups. The time interval from the start of continuous chest pain to TT was also similar between the groups. The left ventricular ejection fraction was higher and there were less frequent ventricular arrhythmias in patients with PA than in those without PA (47.9+/-7.4 versus 44.4+/-8.1, P=0.041, and 17.1% versus 37.5%, P=0.043, respectively). The clinical reperfusion time was significantly shorter in the patients with PA than in those without PA (68.2+/-24.5 min versus 81.4+/-19.3, P=0.012). The clinical reperfusion time was positively correlated with age and the time interval from the start of continuous chest pain to TT but inversely related to the presence of PA.
CONCLUSIONS: In patients with AMI preceded by PA, TT resulted in more rapid clinical reperfusion than in patients without PA. Thus, earlier myocardial reperfusion may account for smaller infarct size and better prognosis in patients with PA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239974

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

1.  Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).

Authors:  David E Winchester; Rhonda M Cooper-Dehoff; Yan Gong; Eileen M Handberg; Carl J Pepine
Journal:  Clin Cardiol       Date:  2013-05-29       Impact factor: 2.882

2.  One-Year Outcome of Patients with Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks.

Authors:  Alireza Amirzadegan; Seyed-Ali Sadre-Bafghi; Saeed Ghodsi; Hamidreza Soleimani; Mehrnaz Mohebi; Ebrahim Nematipour; Ali-Mohammad Haji-Zeinali; Mojtaba Salarifar; Hamidreza Pourhosseini; Yones Nozari; Masih Tajdini; Hassan Aghajani; Mohammad Alidoosti; Yaser Jenab; Negar Omidi; Arash Jalali; Zahra Hosseini
Journal:  J Tehran Heart Cent       Date:  2020-10

3.  DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.

Authors:  Yen-Ta Chen; Christopher Glenn Wallace; Chih-Chao Yang; Chih-Hung Chen; Kuan-Hung Chen; Pei-Hsun Sung; Yung-Lung Chen; Han-Tan Chai; Sheng-Ying Chung; Sarah Chua; Fan-Yen Lee; Sheung-Fat Ko; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.